Treatment of Persistent Cutaneous Atrophy After Corticosteroid Injection With Fat Graft

Nádia Martins; Joaquim Polido-Pereira; Manuel Caneira; João Eurico Fonseca

doi:10.1016/j.reuma.2017.09.002

Treatment of Persistent Cutaneous Atrophy After Corticosteroid Injection With Fat Graft

Reumatol Clin (Engl Ed). 2019 Nov-Dec;15(6):e122-e124. doi: 10.1016/j.reuma.2017.09.002. Epub 2017 Dec 8.

[Article in English, Spanish]

Authors

Nádia Martins¹, Joaquim Polido-Pereira², Manuel Caneira³, João Eurico Fonseca²

Affiliations

¹ Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal; Rheumatology Department, Hospital de São Teotónio, CHTV, Viseu, Portugal. Electronic address: nadia_filipaem@hotmail.com.
² Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.
³ Plastic Surgery Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.

PMID: 29229449
DOI: 10.1016/j.reuma.2017.09.002

Abstract

Subcutaneous fat atrophy and hypopigmentation are potential adverse side effects of local corticosteroid injection that may resolve spontaneously within 1-2 years. This report shows that fat grafting provides a simple, effective and safe correction of corticosteroid induced cutaneous atrophy with very satisfying esthetic and functional results.

Keywords: Atrofia de la grasa subcutánea; Corticosteroid injections; Fat graft; Hipopigmentación; Hypopigmentation; Injerto de grasa; Inyecciones de corticosteroides; Subcutaneous fat atrophy.

Publication types

Case Reports

MeSH terms

Adipose Tissue / transplantation*
Atrophy / chemically induced
Atrophy / surgery
Dermatologic Surgical Procedures
Female
Glucocorticoids / administration & dosage
Glucocorticoids / adverse effects*
Humans
Injections
Methylprednisolone / administration & dosage
Methylprednisolone / adverse effects*
Middle Aged
Skin / pathology*

Substances

Glucocorticoids
Methylprednisolone